Evidence map›Paper›PMID 30463587›Full record

ReviewStem cell research & therapy2018

Human menstrual blood: a renewable and sustainable source of stem cells for regenerative medicine.

Haining Lv, Yali Hu, Zhanfeng Cui, Huidong Jia

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Haining LvDepartment of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Graduate School of Peking Union Medical College, 321 Zhongshan Road, Nanjing, China.
Yali HuDepartment of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Graduate School of Peking Union Medical College, 321 Zhongshan Road, Nanjing, China. yalihu@nju.edu.cn.
Zhanfeng CuiTissue Engineering Group, Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, ORCRB, Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK.
Huidong JiaTissue Engineering Group, Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, ORCRB, Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK. huidong.jia@eng.ox.ac.uk.ORCID 0000-0001-5216-2421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells (SCs) play an important role in autologous and even allogenic applications. Menstrual blood discharge has been identified as a valuable source of SCs which are referred to as menstrual blood-derived stem cells (MenSCs). Compared to SCs from bone marrow and adipose tissues, MenSCs come from body discharge and obtaining them is non-invasive to the body, they are easy to collect, and there are no ethical concerns. There is, hence, a growing interest in the functions of MenSCs and their potential applications in regenerative medicine. This review presents recent progress in research into MenSCs and their potential application. Clinical indications of using MenSCs for various regenerative medicine applications are emphasized, and future research is recommended to accelerate clinical applications of MenSCs.

Indexed as

Regenerative MedicineBlood CellsCell Culture TechniquesCell DifferentiationCell ProliferationCell TransplantationFemaleHumansMenstruationStem CellsMenstrual bloodMenstrual blood-derived stem cellsRegenerative medicine

Identifiers

PMID30463587
PMCPMC6249727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.